CA50785-7 - 0x000000000000753F
Healthy Males & Females
Forward
* Stipend may pay up to reflected amount.
Start Date:
December 9, 2026 - 3:15pm
End Date:
December 17, 2026 - 9:45am
Study Details
Study Number: CA50785
Group Number: 7
Study Requirement: Healthy Normal Male and Female
Stipend: up to $3,250.00
Study Criteria
Age: 19 - 55
BMI: 18 - 30
Weight Restriction: minimum weight 111 lbs
Study Information
Indication: This investigational medication is being developed for the treatment of multiple sclerosis (MS).
Route of Administration: Oral
Blood Draws: 16
Study Schedule
Schedule Type: Short stays with returns
Study Length: 3 Night Stay & 2 Returns
Screening Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 11/24/2026 |
| Wednesday | 12/2/2026 |
Doctor Exam Dates:
| Event Day | Event Date |
|---|---|
| Tuesday | 11/24/2026 |
| Wednesday | 12/2/2026 |
Study Dates:
| Event Type | Start Day | Start Date | End Day | End Date | Phase | Site |
|---|---|---|---|---|---|---|
| Check-In | Wednesday | 12/9/2026 3:15:00 PM | Saturday | 12/12/2026 9:45:00 AM | 1 | Lincoln |
| Return | Monday | 12/14/2026 8:45:00 AM | Monday | 12/14/2026 9:45:00 AM | 1 | Lincoln |
| Return | Thursday | 12/17/2026 8:45:00 AM | Thursday | 12/17/2026 9:45:00 AM | 1 | Lincoln |


